Laurence Tam
Stock Analyst at Morgan Stanley
(3.65)
# 2,127
Out of 5,073 analysts
41
Total ratings
69.2%
Success rate
13%
Average return
Main Sectors:
Stocks Rated by Laurence Tam
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $57.00 | $47.74 | +19.40% | 11 | Sep 16, 2026 | |
| HKG: 6821 Asymchem Laboratories (Tianjin) Co., Ltd. | Reiterated: Hold | $120.00 → $134.00 | $126.50 | +5.93% | 2 | Aug 25, 2026 | |
| HKG: 2268 WuXi XDC Cayman Inc. | Reiterated: Buy | $60.00 → $88.00 | $74.35 | +18.36% | 2 | Nov 21, 2025 | |
| HKG: 0570 China Traditional Chinese Medicine Holdings Co. Limited | Reiterated: Sell | $1.60 | $1.15 | n/a | 7 | Oct 17, 2025 | |
| HKG: 1099 Sinopharm Group Co. Ltd. | Reiterated: Buy | $25.00 → $22.50 | $15.44 | n/a | 4 | Aug 22, 2025 | |
| HKG: 3880 Medtide Inc. | Initiated Coverage: Hold | $38.00 | $19.65 | n/a | 1 | Aug 6, 2025 | |
| HKG: 0874 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | Reiterated: Hold | $21.70 → $21.40 | $12.85 | n/a | 4 | Dec 23, 2024 | |
| HKG: 2607 Shanghai Pharmaceuticals Holding Co., Ltd | Reiterated: Buy | $17.50 → $17.00 | $11.01 | n/a | 3 | Dec 23, 2024 | |
| HKG: 3320 China Resources Pharmaceutical Group Limited | Reiterated: Buy | $7.80 → $7.50 | $4.46 | n/a | 3 | Sep 17, 2024 | |
| HKG: 9989 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. | Reiterated: Hold | $3.50 | $3.94 | n/a | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6.10 | $3.04 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17.00 → $15.00 | $5.59 | n/a | 2 | Mar 15, 2024 |
WuXi Biologics (Cayman) Inc.
Sep 16, 2026
Reiterated: Buy
Price Target: $57.00
Current: $47.74
Upside: +19.40%
Asymchem Laboratories (Tianjin) Co., Ltd.
Aug 25, 2026
Reiterated: Hold
Price Target: $120.00 → $134.00
Current: $126.50
Upside: +5.93%
WuXi XDC Cayman Inc.
Nov 21, 2025
Reiterated: Buy
Price Target: $60.00 → $88.00
Current: $74.35
Upside: +18.36%
China Traditional Chinese Medicine Holdings Co. Limited
Oct 17, 2025
Reiterated: Sell
Price Target: $1.60
Current: $1.15
Upside: n/a
Sinopharm Group Co. Ltd.
Aug 22, 2025
Reiterated: Buy
Price Target: $25.00 → $22.50
Current: $15.44
Upside: n/a
Medtide Inc.
Aug 6, 2025
Initiated Coverage: Hold
Price Target: $38.00
Current: $19.65
Upside: n/a
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Dec 23, 2024
Reiterated: Hold
Price Target: $21.70 → $21.40
Current: $12.85
Upside: n/a
Shanghai Pharmaceuticals Holding Co., Ltd
Dec 23, 2024
Reiterated: Buy
Price Target: $17.50 → $17.00
Current: $11.01
Upside: n/a
China Resources Pharmaceutical Group Limited
Sep 17, 2024
Reiterated: Buy
Price Target: $7.80 → $7.50
Current: $4.46
Upside: n/a
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Sep 17, 2024
Reiterated: Hold
Price Target: $3.50
Current: $3.94
Upside: n/a
Apr 17, 2024
Reiterated: Hold
Price Target: $6.10
Current: $3.04
Upside: n/a
Mar 15, 2024
Reiterated: Buy
Price Target: $17.00 → $15.00
Current: $5.59
Upside: n/a